Suppr超能文献

短链脂肪酸受体与血压调节:2021 年高血压学会中青年研究卓越奖。

Short-Chain Fatty Acid Receptors and Blood Pressure Regulation: Council on Hypertension Mid-Career Award for Research Excellence 2021.

机构信息

Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, MD.

出版信息

Hypertension. 2022 Oct;79(10):2127-2137. doi: 10.1161/HYPERTENSIONAHA.122.18558. Epub 2022 Aug 1.

Abstract

The gut microbiome influences host physiology and pathophysiology through several pathways, one of which is microbial production of chemical metabolites which interact with host signaling pathways. Short-chain fatty acids (SCFAs) are a class of gut microbial metabolites known to activate multiple signaling pathways in the host. Growing evidence indicates that the gut microbiome is linked to blood pressure, that SCFAs modulate blood pressure regulation, and that delivery of exogenous SCFAs lowers blood pressure. Given that hypertension is a key risk factor for cardiovascular disease, the examination of novel contributors to blood pressure regulation has the potential to lead to novel approaches or treatments. Thus, this review will discuss SCFAs with a focus on their host G protein-coupled receptors including GPR41 (G protein-coupled receptor 41), GPR43, and GPR109A, as well as OLFR78 (olfactory receptor 78) and OLFR558. This includes a discussion of the ligand profiles, G protein coupling, and tissue distribution of each receptor. We will also review phenotypes relevant to blood pressure regulation which have been reported to date for , and knockout mice. In addition, we will consider how SCFA signaling influences physiology at baseline, and, how SCFA signaling may contribute to blood pressure regulation in settings of hypertension. In sum, this review will integrate current knowledge regarding how SCFAs and their receptors regulate blood pressure.

摘要

肠道微生物组通过多种途径影响宿主生理学和病理生理学,其中一种途径是微生物产生与宿主信号通路相互作用的化学代谢物。短链脂肪酸(SCFAs)是一类已知可激活宿主多种信号通路的肠道微生物代谢物。越来越多的证据表明,肠道微生物组与血压有关,SCFAs 调节血压调节,外源性 SCFAs 降低血压。鉴于高血压是心血管疾病的一个关键危险因素,检查血压调节的新贡献因素有可能导致新的方法或治疗方法。因此,本综述将讨论 SCFAs,重点介绍其宿主 G 蛋白偶联受体,包括 GPR41(G 蛋白偶联受体 41)、GPR43 和 GPR109A ,以及 OLFR78(嗅觉受体 78)和 OLFR558。这包括讨论每种受体的配体谱、G 蛋白偶联和组织分布。我们还将回顾迄今为止报道的 和 基因敲除小鼠与血压调节相关的表型。此外,我们将考虑 SCFA 信号如何在基线水平影响生理学,以及 SCFA 信号如何在高血压情况下有助于血压调节。总之,本综述将整合有关 SCFAs 及其受体如何调节血压的最新知识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7472/9458621/3cedb02faa71/nihms-1823439-f0001.jpg

相似文献

2
The role of short-chain fatty acid on blood pressure regulation.短链脂肪酸在血压调节中的作用。
Curr Opin Nephrol Hypertens. 2016 Sep;25(5):379-83. doi: 10.1097/MNH.0000000000000246.
5
Microbial Short-Chain Fatty Acids and Blood Pressure Regulation.微生物短链脂肪酸与血压调节
Curr Hypertens Rep. 2017 Apr;19(4):25. doi: 10.1007/s11906-017-0722-5.

引用本文的文献

1
Editorial: Gut microbiota-derived metabolites and cardiovascular diseases.社论:肠道微生物群衍生代谢物与心血管疾病
Front Cell Infect Microbiol. 2025 Aug 29;15:1661489. doi: 10.3389/fcimb.2025.1661489. eCollection 2025.
5
Food as Medicine for Hypertension: Microbiota as Mediators.食物作为高血压的药物:微生物群作为介导者。
Hypertension. 2025 Oct;82(10):1569-1589. doi: 10.1161/HYPERTENSIONAHA.125.17950. Epub 2025 Aug 20.

本文引用的文献

4
The Gut Microbiota and Their Metabolites in Human Arterial Stiffness.肠道微生物群及其代谢物与人类动脉僵硬度。
Heart Lung Circ. 2021 Nov;30(11):1716-1725. doi: 10.1016/j.hlc.2021.07.022. Epub 2021 Aug 25.
7
A single-cell type transcriptomics map of human tissues.人类组织单细胞转录组图谱。
Sci Adv. 2021 Jul 28;7(31). doi: 10.1126/sciadv.abh2169. Print 2021 Jul.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验